The current literature regarding kleptomania (KM) is scarce, especially regarding treatment approaches and outcomes. The aims of the present study involved: (1) exploring characteristics of people with KM (with and without co-occurring eating disorders (EDs)); (2) considering KM along an impulsive-compulsive spectrum; and, (3) investigating treatment outcomes in a clinical sample of female patients with KM. The study sample included 150 female participants with either a diagnosis of KM only (n = 13), co-occurring KM and EDs (n = 71), or healthy control individuals (HCs) (n = 66). The KM-only group was diagnosed using DSM-5 criteria and by a face-to-face clinical interviewed. EDs were diagnosed through a face-to-face semi-structured clinical interview based on DSM-5 criteria, and co-occurring KM was self-reported by patients. Psychopathology, impulsivity and personality features were assessed. Clinical groups received cognitive behavioral treatment. Compared to HCs, both KM groups reported more psychopathology, higher impulsivity, and more dysfunctional personality features. Relative to the clinical groups, that with KM + ED was more impulsive; in contrast, harm avoidance scores were higher in the KM-only group. Both clinical groups present poor treatment outcomes. KM can present impulsive and compulsive features, and these may impact treatment outcomes. Co-occurring KM and EDs may worsen clinical profiles and warrant specific interventions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11885670 | PMC |
http://dx.doi.org/10.1038/s41598-025-85705-9 | DOI Listing |
J Med Internet Res
March 2025
Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Background: Acceptance and commitment therapy provides a psychobehavioral framework feasible for digital and hybrid weight loss interventions. In face-to-face studies, group-based interventions yield more favorable outcomes than individual interventions, but the effect of the intervention form has not been studied in combination with eHealth.
Objective: This study investigated whether a minimal, 3-session group or individual enhancement could provide additional benefits compared to an eHealth-only intervention when assessing weight, body composition, and laboratory metrics in a sample of occupational health patients with obesity.
JMIR Res Protoc
March 2025
Paseo de los Encomendadores, Faculty of Health Sciences, University of Burgos, Burgos, Spain.
Background: Breast cancer is the second most common cancer in women worldwide. Treatments for this disease often result in side effects such as pain, fatigue, loss of muscle mass, and reduced quality of life. Physical exercise has been shown to effectively mitigate these side effects and improve the quality of life in patients with breast cancer.
View Article and Find Full Text PDFBlood
March 2025
Vanderbilt UniversityVanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Nashville, Tennessee, United States.
Recurrent ischemic priapism is a common complication of sickle cell anemia (SCA) and is associated with devastating physical and psychosocial consequences. All previous trials for priapism prevention have failed to demonstrate clear efficacy. We conducted a randomized, controlled, double-blind phase 2 feasibility trial comparing fixed moderate-dose hydroxyurea plus placebo (usual care arm) versus fixed moderate-dose hydroxyurea plus tadalafil (experimental arm) in 64 men (18- 40 years) with at least three episodes of SCA-related priapism in the past 12 months.
View Article and Find Full Text PDFPediatr Infect Dis J
March 2025
Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
Background: Congenital cytomegalovirus is the leading cause of nongenetic sensorineural hearing loss. Treatment with (val)ganciclovir improves audiologic outcomes. Neutropenia is a common adverse event, but correlates that predict who will develop neutropenia have not been identified.
View Article and Find Full Text PDFPain Med
March 2025
Department of Anesthesiology and Pain Medicine, Université de Montréal, 2900 Boul. Edouard-Montpetit, Montréal, Québec, H3T 1J4, Canada.
Design: Platelet-rich plasma (PRP) is a popular treatment option in managing chronic tendinopathies, although the literature is inconsistent, mainly because of significant heterogeneity in patient populations. Patients who failed conservative management may respond differently than those who have not undergone first-line treatment. This systematic review and meta-analysis aimed to evaluate the efficacy of PRP injections in reducing pain and improving function in patients with chronic tendinopathy who failed conservative treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!